Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: (So, the consensus is)

I can go with your sound reasoning on the "acquisition now" thing. Is doing it later, after things are better known, that much worse? (i.e., does it matter THAT much when we may only talking weeks till things are much better known?).

I could go with an acquisition now or later. But recognizing that the company is opting for later, I'd sure like to see some major stock buy backs now.

SGE

Share
New Message
Please login to post a reply